News

Vaccinations for Covid-19 are now underway in the U.S. Two vaccines – one from Pfizer and BioNTech, one from Moderna — have ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Center at UCSF is pioneering the development of potent drug candidates aimed at preventing future coronavirus pandemics.
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...
Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
The high number of cases affected nurses and doctors, and also changed the study of medicine. Vice President and Head of ...
The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval commitment ...
The SARS-CoV-2 virus that causes COVID-19 emerged to cause millions of deaths and sicken billions of people... | Microbiology ...
AVI-4303, which is a C5 benzotriazole analog, exhibited ten-fold higher potency than AVI-3318. Comparatively, N1 propargyl ...
UK biotech Synairgen saw the value of its shares crater after its inhaled interferon beta therapy SNG001 was found to provide no benefit to people hospitalised with COVID-19. The drug ...